Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

Recall of Single Lot of Dr. Reddy's Fexofenadine 180 mg Tablets
Dr. Reddy's Laboratories Ltd. has recalled a single lot of Fexofenadine 180 mg tablets. The lot number involved in the recall is lot number C90833. These recalled tablets may be oversized and contain more drug than appropriate. This could result in patients receiving more than the expected dosage of this drug. Fexofenadine is used in the treatment of allergic rhinitis and urticaria (hives) and is also known by the brand name Allegra. However, no other lot numbers, strengths, or brands of Fexofenadine were affected by this recall. For more information please visit: http://online.wsj.com/article/SB125430875357452197.html?mod=googlenews_wsj#articleTabs%3Darticle
Learn More

Teva Pharmaceuticals USA. Recalls Single Lot of Fexofenadine Hydrochloride Tablets USP, 180 mg
Teva Pharmaceuticals USA has recalled a single lot of Fexofenadine Hydrochloride Tablets USP, 180 mg. Lot number 26F109 is being recalled because this lot did not meet the Food and Drug Adminstration’s (FDA) standards for testing and quality during manufacturing. Fexofenadine is used in the treatment of allergies. Fexofenadine is also sold under the brand name Allegra. No other lots, strengths, or brands of Fexofenadine were involved in this recall. To view the FDA notice about this recall, please visit: http://www.fda.gov/Safety/Recalls/EnforcementReports/ucm253935.htm
Learn More

Date Published Title Drug Source
2009-09-30 Recall of Single Lot of Dr. Reddy's Fexofenadine 180 mg Tablets Fexofenadine Manufacturer
2011-05-27 Teva Pharmaceuticals USA. Recalls Single Lot of Fexofenadine Hydrochloride Tablets USP, 180 mg Fexofenadine FDA
2011-06-09 FDA Issues Drug Safety Communication: Finasteride (Proscar, Propecia), Dutasteride (Avodart, Jalyn) May Increase the Risk of a More Serious Form of Prostate Cancer Finasteride FDA
2012-04-13 FDA Updates Prescribing Information for Finasteride (Propecia, Proscar) Finasteride FDA
2011-12-14 Novartis Looking into Death of MS Patient Who Took Gilenya Fingolimod MediGuard CRT
2011-12-20 FDA Announces Safety Review of a Reported Death After the First Dose of Gilenya Fingolimod FDA
2012-04-16 Novartis Issues Safety Information Update Gilenya (fingolimod) Fingolimod Manufacturer
2012-05-14 FDA Revises Recommendations for Heart Monitoring and Use of Multiple Sclerosis Drug Gilenya (Fingolimod) Fingolimod FDA
2013-08-29 FDA Investigating Report of Progressive Multifocal Leukoencephalopathy (PML) in Patient Taking Gilenya (Fingolimod) Fingolimod FDA
2008-09-18 FDA Stops Imports of Ranbaxy Products Fluconazole FDA
2011-08-03 FDA Warns: Risk of Birth Defect with Long-Term, High-Dose Fluconazole During Pregnancy Fluconazole FDA
2010-04-15 Asthma and COPD Inhalers That Contain Ozone-depleting CFCs to be Phased Out; Alternative Treatments Available Flunisolide Inhalation FDA
2012-09-17 Galderma Laboratories Recalls Several Lots of Capex Shampoo FDA
2012-10-08 Hill Dermaceuticals Inc Recalls Several Lots of Derma-Smoothe/FS 0.01% Topical Oil (Scalp Oil) and Body Oil FDA
2010-04-12 Nycomed US, Inc. Recalls select lots of Fluocinonide Ointment USP, 0.05% Fluocinonide FDA
2012-02-02 Taro Pharmaceuticals USA, Inc. Recalls Several Lots of Fluocinonide, Ointment USP, 0.05% Fluocinonide FDA
2015-08-25 Allergan Issues Voluntary Recall of Select Lots Of REFRESH Lacri-Lube, REFRESH P.M., FML, and Blephamide Over Safety Concerns Fluorometholone FDA
2011-08-16 Taro Pharmaceuticals Recalls Select Lots of Fluorouracil Topical Cream, 5% Fluorouracil FDA
2009-01-12 New Antidepressant Guide for Patients Fluoxetine FDA
2012-02-02 Sandoz Inc. Recalls Single Lot of Fluoxetine Capsules 10 mg Fluoxetine FDA
Back to Consumer Med Safety